Last reviewed · How we verify
Mydriacyl Ophthalmic Product — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Mydriacyl Ophthalmic Product (Mydriacyl Ophthalmic Product) — Mantis Photonics AB.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mydriacyl Ophthalmic Product TARGET | Mydriacyl Ophthalmic Product | Mantis Photonics AB | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mydriacyl Ophthalmic Product CI watch — RSS
- Mydriacyl Ophthalmic Product CI watch — Atom
- Mydriacyl Ophthalmic Product CI watch — JSON
- Mydriacyl Ophthalmic Product alone — RSS
Cite this brief
Drug Landscape (2026). Mydriacyl Ophthalmic Product — Competitive Intelligence Brief. https://druglandscape.com/ci/mydriacyl-ophthalmic-product. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab